Search for on  
Saturday, November 21, 2009
     
 Home
 About CWA
 Join CWA
 Give/Donate
- Donate Now
- More Ways to Give
 Get Involved
- Federal
- State/Local
 Media Center
- CWA Experts
- Press Releases
- CWA In The News
- CWA Op/Eds
 Legislation
 Beverly LaHaye
 Institute
 Culture and Family Issues
 Legal Studies
 Family Voice
- Subscribe Online!
 Multimedia
 Shop CWA
 About CWA
 CWALAC
 Project 535
 Employment
 Internships
 Brochures
 Fact Cards
 Recently on CWA
 Links

CWA of Central California – Beyond the TEA Parties
November 14, 2009
San Jose, CA

CWA of Iowa – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of North Dakota – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of Maine – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of Ohio – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of Virginia – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of South Dakota – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of Oklahoma – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of New Hampshire – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of Hawaii – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide

CWA of Louisiana – National Day of Fasting, Repentance & Prayer
November 19, 2009
State Wide


 

CWA Urges the FDA to Reject Political Pressure on the Morning-After Pill     1/7/2005

Washington, D.C. – Concerned Women for America (CWA) urged the Food and Drug Administration (FDA) to reject political pressure to permit over-the-counter distribution of the morning-after pill, or Plan B, saying that the drug poses harm to women’s health.

“A recent study showed that easy access to the morning-after pill has no impact on the pregnancy rate, as proponents claim,” said Wendy Wright, CWA’s senior policy director. “Also alarming is that studies indicate that easy access to the drug increases sexually transmitted disease (STD) rates. Furthermore, studies show that the abortion rate is unaffected, and in some cases has increased.”

Wright testified at the FDA Advisory Committee hearing in December 2003 when the morning-after pill was under review for over-the-counter status. The FDA refused to grant over-the-counter status due to insufficient data on the impact of easy access to the drug on adolescents.

Barr Laboratories filed a new application for the drug to be available to anyone over 16, but requiring under-16-year-olds to have a prescription.

“As we all know from alcohol and tobacco sales, the person who would buy the drug is not necessarily the person who would consume it. There would be no way to enforce this marketing scheme, and would put women and girls at risk of unscrupulous people who could slip the drug to them without their knowledge or consent,” Wright said.

The deadline for the FDA’s decision is Jan. 22, 2005.



Bookmark and Share

For Information Contact:
Demi Bardsley
(202) 309-5978
media.cwfa.org

Printer Friendly Version

Recent Articles
SpeakOut Illinois 2010 and TeenSpeak 2010 Registrations
House Strips Abortion Funding from Health Care Bill
Knock, Knock: We’re Here!
CWA joins Michele Bachmann's 'House Call' on Congress
Pelosi’s Bill Supported by Partial-Birth Abortionist
Now's the Time to Stop the Abomination of ObamaCare
ObamaCare = Coerced Abortions
Petitions Against Federal Funding of Abortion Delivered to Capitol Hill
ObamaCare and the Doctor Shortage
40 Days for Life
Testimony Before the Senate Health, Education, Labor, and Pensions Committee

 

 
 

 

Concerned Women for America
1015 Fifteenth St. N.W., Suite 1100
Washington, D.C. 20005
Phone: (202) 488-7000
Fax: (202) 488-0806

Feedback / Questions? || Problem with this page? || Archives



 
    ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... ..... .....